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ABSTRACT 
International Journal of Exercise Science 9(4): 482-490, 2016. Previous studies have 
investigated carotid artery intima-media thickness (IMT) and blood pressure and found a direct 
correlation between the two. It is known that adult females have better cardiovascular health 
than males until a certain stage of life, yet limited research has examined gender differences in 
vascular function. Thus, the purpose of this study was to investigate vascular structure and 
function, blood pressure, and blood glucose/cholesterol levels in relation to gender differences in 
young healthy adults. On three separate days, 44 adults (26.30 ±11.9yrs; 24M, 20F) completed a 
carotid IMT ultrasound, a flow-mediated dilation (FMD), a fasted glucose and cholesterol test, a 
24hr ambulatory blood pressure monitoring, a VO2max test, and a body composition 
measurement. Females had lower systolic blood pressure, lower diastolic blood pressure, lower 
LDL/HDL ratios, lower body mass index, a higher HDL count, and lower plasma glucose levels 
than males (p < 0.05 for all), all of which suggest better cardiovascular health. However, we 
found no gender differences in vascular health measures, IMT and FMD. Our results suggest that 
while young adult females have better cardiovascular health than males, endothelial function 
may not yet be affected in the young adult years. 
 
 
KEY WORDS: Blood pressure, intima-media thickness, cardiovascular, 
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INTRODUCTION 
 
Cardiovascular (CV) disease is the leading 
cause of death in the world (4). Several CV 
disease risk factors include blood pressure, 
carotid artery intima-media thickness 
(IMT), flow-mediated dilation (FMD), 
volume of oxygen consumption (VO2max), 
body composition, plasma fasted glucose, 
high density lipoprotein (HDL), low 
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density lipoprotein (LDL), and total 
cholesterol levels (15). Hypertension is 
defined as sustained elevation of brachial 
blood pressure and remains a common risk 
factor of CV disease (5, 17). Hypertension 
and CV disease are related to both vascular 
structure, measured by carotid artery IMT, 
and vascular function, assessed by FMD 
(14, 19). Research suggests that increased 
thickness of major arteries, such as the 
carotid artery, and impaired vascular 
function are early indicators of CV disease 
(21, 24). Separately, it has been shown that 
adults who were more physically active 
had better vascular health, and were 
therefore at a lower risk for CV disease (2, 
26).  
 
Increasingly, physicians are recommending 
ambulatory blood pressure (ABP) 
monitoring to assess hypertension in 
patients. ABP is a 24-hour home blood 
pressure monitoring system, which has 
been recommended for the identification of 
white coat hypertension, masked 
hypertension, nocturnal hypertension, well-
controlled hypertension, and hypotension 
(3, 22). Finally, cholesterol levels are closely 
related to hypertension and CV disease. 
Previously, it has been shown that high 
LDL blood levels are associated with larger 
carotid IMT (18), and high HDL levels are 
associated with smaller carotid artery IMT 
measurements (29).  
 
Hypertension is a serious risk factor of CV 
disease in both genders, and it has been 
proven that women with hypertension are 
more likely to have increased additional 
risk factors  (increased total cholesterol, 
decreased LDL levels, and hyperglycemia) 
present compared to men (23). Women with 
hypertension were more likely to be older 
and have a higher BMI than men, which 
puts them at additional risk for a CV event 
(23).  Also, research has shown that females 
have lower carotid IMT values, which 
suggests better CV health (16). In addition, 
throughout early adulthood in females, 
HDL levels are inversely related to carotid 
IMT measurements, but once women reach 
menopause the anti-atherogenic effects 
seem to diminish (11). Despite all of this, 
multiple studies have found that men are 
more likely to be hypertensive earlier in life 
(9, 28). One study found that hypertension 
is more prevalent in men until the sixth 
decade of life, which is when more women 
develop hypertension (28). 
 
Despite the high number of cardiovascular 
studies conducted, limited research has 
examined gender differences in vascular 
function. Thus, the purpose of this study 
was to investigate vascular structure and 
function, blood pressure, and blood 
glucose/cholesterol levels in relation to 
gender differences in young healthy adults. 
 
METHODS 
 
Participants 
Adult participants were recruited and 
asked to undergo a fasted test, a maximal 
graded exercise test, and wear a 24-hour 
ABP monitor, each of which occurred on 
three separate days. The fasted test 
consisted of FMD, carotid artery IMT, and a 
plasma glucose and cholesterol assessment. 
Only participants who completed these 
three portions of the study were included in 
this analysis. Data were collected and 
analyzed for 24 male participants and 20 
female participants. Zero participants were 
excluded due to compliance reasons, 
although one participant was excluded due 
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to consumption of hypertension 
medication.  
 
Specific criteria for inclusion were: non-
diabetic, non-smoking, no medications that 
affect CV hemodynamics, no more than one 
anti-hypertensive medication, and no 
evidence or history of CV disease, 
hypercholesterolemia, or renal disease. 
Each participant gave written informed 
consent. The protocol was approved by the 
Ursinus College Institutional Review 
Board, and all procedures were in 
accordance with the ethical standards of the 
Helsinki Declaration.   
 
Protocol 
Office (clinic) blood pressure measurements 
were obtained in accordance with JNC-7 
guidelines by laboratory personnel on three 
separate visits in a quiet (five minutes of 
rest), temperature controlled room (6), 
using an aneroid sphygmomanometer 
(Medline Industries, Model MDS9410, 
Mundelein, IL). Blood pressure 
measurements were performed in triplicate 
with the average of the three values used as 
the representative blood pressure for that 
visit. The mean systolic and diastolic blood 
pressure across the three visits is reported 
as the clinic blood pressure.  
 
Twenty-four hour ABP monitoring was 
completed using a non-invasive portable 
blood pressure monitor (SpaceLabs, Model 
90217, Redmond, WA), as previously 
described (8). Monitoring began in the 
morning of each participant’s typical day. 
Blood pressure measures were obtained at 
30-min intervals during the day (6:00am-
10:00pm) and 60-min intervals at night 
(10:00pm-6:00am). The following morning, 
each participant was asked to list his or her 
waking hours to be used as the daytime 
blood pressure and sleep hours to be used 
as the nighttime blood pressure. Participant 
data were included in final analysis if more 
than 70% of the measurements were 
collected. Mean values were calculated for 
24-hour average, daytime (awake), and 
nighttime (sleep) time frames.   
 
Fasted plasma glucose and cholesterol 
levels were measured in participants using 
the Alere Cholestech LDX® lipid profile 
system (San Diego, CA). Blood was 
obtained by finger stick using a 35 µL 
lithium heparin-coated capillary tube, and 
tested immediately. Lipid profile test 
cassettes were inserted into the Cholestech 
system to analyze blood samples.  
Previously, finger stick Alere Cholestech 
LDX® lipid profile values were correlated 
(r>0.95) with venous plasma values 
measured in clinical diagnostic laboratories 
(Alere), which meets the National 
Cholesterol Education Program criteria for 
agreement between methods (10). 
  
Participants were asked to refrain from 
food, exercise, medication, and caffeine for 
at least 10 hours prior to the test.  The 
participant’s height and weight were 
measured using a calibrated electronic scale 
without shoes. Body composition was 
measured in participants by whole-body 
bioelectrical impedance (BIA) using the 
single frequency impedance instrument 
(ImpediMed DF50, San Diego, CA) in a 
quiet, temperature-controlled room 
following an overnight fast. BIA was 
measured in accordance with the 
manufacturer’s instructions at 50 kHz on 
the right side of the body. Two electrodes 
were placed on the dorsal right hand and 
foot while the participants were lying in a 
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supine position, and all electrode sites were 
cleaned with an alcohol swab before 
attachment. Three measurements were 
taken, and the mean values of impedance 
phase, resistance, and reactance were used 
for calculations of total fat mass and total 
fat free mass. 
 
A maximal graded Bruce protocol exercise 
test was performed with continuous breath-
by-breath gas sampling to measure oxygen 
consumption (VO2) using a calibrated 
metabolic cart (TrueOne 2400, 
ParvoMedics, Sandy, UT).  
Electrocardiogram was continuously 
monitored by laboratory researchers (Nasiff 
CardioCard, Nasiff Associates, Central 
Square, NY). Blood pressure, heart rate, and 
perceived exertion were measured at each 
stage. The treadmill test was terminated 
using termination criteria according to 
American College of Sports Medicine 
Guidelines for Exercise Prescription and the 
American Heart Association (13). 
 
Brachial artery diameter measurements 
using FMD were collected in a quiet room 
with no temperature variability, subsequent 
to a ten-hour overnight fast. Upon arrival, 
each participant was given a 20-minute 
resting time period for acclimation and to 
achieve a hemodynamic steady state. A 3-
lead ECG was used to continuously 
measure heart rate. In addition, blood 
pressure was measured in the left arm to 
confirm a steady hemodynamic state. A 
5x84-cm automatic cuff (E-20 rapid cuff 
inflator; D.E. Hokanson Bellevue, WA) was 
placed around the forearm just distal to the 
olecranon process, in accordance with 
current guidelines for obtaining FMD 
measures (7). Baseline images were 
obtained 2 to 10 cm superior to the 
antecubital fossa by 2D high resolution 
ultrasound system, using a 5 to 12 MHz 
multifrequency linear array transducer. 
Once a quality image was obtained, the 
right arm was supported, the position on 
patient arm marked, and the transducer 
was stabilized using a clamp. Minor 
corrections of transducer placement were 
made to maintain optimal imaging. 
Doppler velocity was also obtained through 
ultrasound imaging. Doppler flow signals 
were set at an insonation angle of 60°, and 
measurements were recorded with the 
sample volume placed along the middle of 
the artery. For 30 seconds, baseline 
measures were taken simultaneously with 
Doppler measurements for blood velocity 
and 2D ultrasound imaging for diameter. 
The automatic forearm cuff was then 
inflated to 250 mmHg and held at a 
constant pressure for 5 minutes. Diameter 
and velocity recordings resumed prior to 
cuff deflation and continued for 2 
subsequent minutes as post-ischemia 
images were acquired. Ultrasound FMD 
videos were obtained with the GE Logiq E 
(Model BT12, GE Medical Systems, 
Chicago, IL), downloaded to a separate 
computer, and converted using Movavi 
Video Editor (Movavi, St Louis, MO). 
Arterial diameters were interpreted using 
the Brachial Analyzer for Research 
(Brachial Analyzer Version 6, Medical 
Imaging Applications, Coralville, IA). The 
highest 10 second interval throughout the 2 
minute post-ischemic collection period 
represented the peak hyperemic diameter. 
Velocity and diameter measurements were 
converted to local shear stress using the 
following equation (20). Shear Stress = 8 x µ 
x VH/DBL, where µ is blood viscosity, 
assumed to be 0.035 dyne seconds/cm2, VH 
is the peak post-hyperemia velocity, and 
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DBL represents the baseline diameter. FMD 
reported is the percent increase in diameter 
from baseline and is calculated as FMD = 
(peak hyperemic diameter – baseline 
diameter) / baseline diameter. The same 
operator performed all FMD 
measurements. 
 
On the same day as FMD measurements, 
carotid artery IMT images were recorded 
and automatically calculated as previously 
described (12). Images were obtained and 
measurements made, for the right side 
common carotid artery, using the GE Logiq 
E ultrasound system and automated 
calculation software (Auto-IMT Software 
Option, GE Medical Systems, Chicago, IL). 
Three measures were collected of the 
posterior wall of the common carotid 
artery, as per established guidelines (25). 
The average of all the readings was 
calculated, and this value is reported. In 
our laboratory, the intraclass correlation 
coefficient for FMD is >0.84 and the ICC for 
average IMT is >0.94. 
 
Statistical Analysis 
Data are expressed as mean ± standard 
deviation (SD). Distribution of all variables 
was examined using the Shapiro-Wilk test 
of normality. Nonparametric tests were 
used when appropriate. Participants were 
split into two groups, males and females, 
for analysis. Independent t-tests were used 
to compare differences between males and 
females. Statistical significance was set a 
priori at p < 0.05. All statistical analyses 
were performed using SPSS version 19.0 
(SPSS Inc., Chicago, IL, USA). 
 
RESULTS 
 
Table 1 lists the participant characteristics. 
The sample of our study consisted of 44 
participants (26.3 ± 11.9 yrs, 24 M, 20F). 
Average values for our whole sample 
group, male sample group, and female 
sample group can be found in Table 1.   
 
Table 1. Participant Characteristics 
Data are presented as mean ± standard deviation. 
BMI, body mass index; VO2max, maximum oxygen 
consumption; BP, blood pressure; HDL, high density 
lipoprotein; LDL, low density lipoprotein.  
 
Significant differences were found between 
gender in several CV health measures. Male 
BMI was significantly greater than female 
BMI, as is shown in Table 1. Male systolic 
and diastolic blood pressure were also 
significantly higher than female blood 
pressure (Table 1). HDL cholesterol was 
significantly higher in females, and the 
LDL/HDL ratio was significantly higher in 
males (Table 1).  
 
 
 
 
Whol
e 
Grou
p 
Male
s 
Female
s 
P-Value 
 
Age, yrs 
 
26.3 
±11.9 
 
26.0 
±11.4 
 
26.7 
±12.6 
 
0.841 
BMI, kg/m2 27.6 
±5.8 
29.9 
±5.9 
24.9 
±4.3 
0.002 
VO2max, 
ml/kg/min 
41.7 
±8.6 
41.2 
±9.3 
42.2 
±7.8 
0.698 
Systolic BP, 
mmHg 
121.4 
±8.1 
125.7 
±6.5 
116.2 
±6.6 
0.000 
Diastolic BP, 
mmHg 
Glucose 
 
Cholesterol 
 
Triglycerides 
 
HDL 
 
LDL 
 
LDL/HDL 
75.0 
±5.5 
87.5 
±7.3 
164.2 
±36.7 
101.1 
±61.6 
47.8 
±16.6 
100.4 
±28.7 
2.4  
±1.1 
 
76.9 
±4.5 
91.2 
±5.1 
164.6 
±38.2 
104.6 
±61.6 
39.6 
±13.7 
102.9 
±31.9 
2.82 
± 1.2 
72.7 
±5.8 
83.2 
±7.2 
163.9 
±36.0 
96.5 
±63.1 
57.2 
±14.7 
97.1 
±24.1 
1.73 
±0.62 
0.012 
 
0.000 
 
0.958 
 
0.689 
 
0.000 
 
0.540 
 
0.001 
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Table 2 lists vascular health measures by 
gender. In the entire group, a brachial 
artery baseline diameter and FMD of the 
brachial artery were measured and the 
results are presented in Table 2. Males had 
a significantly larger baseline diameter of 
the brachial artery. 
 
Table 2. Vascular Health by Gender 
 Males Females P-Value 
 
Baseline Diameter 
 
4.21 ± 0.64 
 
3.48 ± 0.38 
 
0.000 
Flow Mediated 
Dilation 
8.16 ± 3.8 6.86 ± 2.6 0.248 
Intima-Media 
Thickness 
0.50 ± 0.09 0.46 ± 0.06 0.095 
    
Data are presented as mean ± SD. 
 
For all forms of measurement, males had a 
significantly higher systolic blood pressure 
(See Figure 1). 
 
Figure 1. Systolic blood pressure differences 
between male and female adults. Values reported 
are means and in units of mmHg. White bars display 
male values and grey bars display female values. 
CSBP, clinic systolic blood pressure; SBP24Avg, 
ambulatory 24-hour systolic blood pressure average; 
SBPMax, maximum systolic blood pressure during 
exercise test; DSBPAvg, daytime 24-hour systolic 
blood pressure; NSBPAvg, night time 24-hour 
systolic blood pressure. *Significant p<0.05, between 
gender groups.   
 
For the entire group, participants had an 
average body fat percentage of 31.3 ± 7.2 %. 
Participants had an average fat mass of 58.4 
± 25.2 lbs and an average fat free mass of 
124.4 ± 13.3 lbs. When compared by gender, 
males were found to have a significantly 
higher BMI and fat free mass while females 
were found to have a significantly higher 
body fat percentage (See Figure 2). 
 
 
Figure 2. Differences in body composition in male 
and female adults. Grey bars display male values 
and white bars display female values. Values are 
means. *Significance p<0.05, between groups.  
DISCUSSION 
 
The main findings of this study are that 
young adult females have lower systolic 
blood pressure, lower diastolic blood 
pressure, lower LDL/HDL ratios, a higher 
HDL count, and lower fasting blood 
glucose levels than males, all of which are 
markers of increased CV health. However, 
we found no gender differences in vascular 
health measures, IMT and FMD. We also 
found that males have a significantly higher 
BMI than females, yet they also have 
significantly lower fat mass and 
significantly higher fat free mass than 
females. Our results suggest that while 
young adult females have better CV health 
than males, endothelial function may not 
yet be affected in the young adult years.  
 
0
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Gender differences in CV health are an 
extremely important topic and female CV 
health research is in high demand. 
Symptoms of CV disease present differently 
in males and females, therefore it is crucial 
to fully understand the gender differences 
among risk factors in order to improve 
prevention and detection of CV disease. It 
was found that men have significantly 
higher BP than females in all of our systolic 
blood pressure measurements (clinic blood 
pressure, 24 hour average, day time 
average, night time average, and max blood 
pressure). Several other studies have also 
concluded that males are more likely than 
females to have elevated blood pressure 
early in life (9, 28).  
 
In our young sample (average age of 26.3 ± 
11.9 yrs), it was found that females have 
healthier cholesterol levels than males. One 
study conducted by Appelman et al. 
examined gender differences in relation to 
CV disease and blood cholesterol levels (1). 
Researchers found that women of younger 
age have increased HDL and decreased 
LDL levels compared to males (1). Similar 
to their findings, we found that women 
have greater HDL levels and a lesser 
LDL/HDL ratio than males. Appelman et 
al. also found that after the menopausal 
transition, female LDL cholesterol levels 
become higher than males (1). As the 
female participants in our sample age, we 
suspect that, as a group, they will 
experience increased cardiovascular risk 
due to the loss of beneficial effects from 
female hormones. 
 
In the current study, gender differences in 
vascular health measures were not 
observed. Since the other CV health 
measures were significantly different 
amongst genders, we inferred that IMT and 
FMD values had not yet been affected in 
our young and healthy population. A study 
conducted by Skaug et al. found that males 
had a higher prevalence of endothelial 
dysfunction than females (27). Skaug et al. 
also observed that the most marked 
reduction of FMD occurred in the early 30’s 
in males and this reduction did not occur in 
females until their 40’s. In both genders, the 
decline in endothelial function occurs 
approximately a decade prior to the largest 
increase in first CV event occurrence (27). In 
the current study, we did not see 
differences in endothelial function. We 
suspect this is because the average age of 
our sample was 26, and according to Skaug 
et al., FMD reduction does not commonly 
occur until the third and fourth decades of 
life. However, in our study we did find a 
significant difference in baseline diameter 
of the brachial artery. Even though vascular 
function is not different between genders, 
the difference in baseline diameter is 
expected because males are generally larger 
than females and subsequently have larger 
arteries. In addition, we found no gender 
differences in vascular structure, measured 
by carotid IMT.  
 
There were several limitations to the 
current study. First, all participants were 
recruited from a suburban area. The sample 
recruited from this area may not be 
indicative of the general population. Also, 
the majority of our sample was comprised 
of college-aged young adults, which 
prevented us from observing the gender 
differences in CV health that are known to 
exist in older adults. 
 
In conclusion, males and females 
experience differences in CV health due to 
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their gender. In our young sample, females 
have better CV health than males as 
evidenced by a lower blood pressure, 
higher HDL count, lower LDL/HDL ratio, 
and lower blood glucose levels. Vascular 
health has not yet been affected by gender 
in this young sample. Future research 
should investigate gender differences in CV 
health at different age ranges across the 
lifespan.  
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